key: cord-0899952-ytu8gmj2
authors: Mohamad, Ebtesam A.; Mohamed, Zahraa N.; Hussein, Mohammed A.; Elneklawi, Mona S.
title: GANE can Improve Lung Fibrosis by Reducing Inflammation via Promoting p38MAPK/TGF-β1/NF-κB Signaling Pathway Downregulation
date: 2022-01-11
journal: ACS Omega
DOI: 10.1021/acsomega.1c06591
sha: 9beca3d63dc1e5cce451149eae159e7217ee8c45
doc_id: 899952
cord_uid: ytu8gmj2

[Image: see text] There is a trend to use nanoparticles as distinct treatments for cancer treatment because they have overcome many of the limitations of traditional drug delivery systems. Gallic acid (GA) is an effective polyphenol in the treatment of tissue injuries. In this study, GA was loaded onto niosomes to produce gallic acid nanoemulsion (GANE) using a green synthesis technique. GANE’s efficiency, morphology, UV absorption, release, and Fourier-transform infrared spectroscopy (FTIR) analysis were evaluated. An in vitro study was conducted on the A549 lung carcinoma cell line to determine the GANE cytotoxicity. Also, our study was extended to evaluate the protective effect of GANE against lipopolysaccharide (LPS)-induced pulmonary fibrosis in rats. GANE showed higher encapsulation efficiency and strong absorption at 280 nm. Transmission electron microscopy presented a spherical shape of the prepared nanoparticles, and FTIR demonstrated different spectra for the free gallic acid sample compared to GANE. GANE showed cytotoxicity for the A549 carcinoma lung cell line with a low IC(50) value. It was found that oral administration of GANE at 32.8 and 82 mg/kg.b.w. and dexamethasone (0.5 mg/kg) provided significant protection against LPS-induced pulmonary fibrosis. GANE enhanced production of superoxide dismutase, GPx, and GSH. It simultaneously reduced the MDA level. The GANE and dexamethasone, induced the production of IL-4, but suppressed TNF-α and IL-6. On the other hand, the lung p38MAPK, TGF-β1, and NF-κB gene expression was downregulated in rats administrated with GANE when compared with the LPS-treated rats. Histological studies confirmed the effective effect of GANE as it had a lung-protective effect against LPS-induced lung fibrosis. It was noticed that GANE can inhibit oxidative stress, lipid peroxidation, and cytokines and downregulate p38MAPK, TGF-β1, and NF-κB gene expression to suppress the proliferation and migration of lung fibrotic cells.

Pulmonary fibrosis is a group of lung diseases in which collagen deposition and fibroblast proliferation cause normal tissues to be replaced with a scar one. 1 Fibrotic illness can be caused by heavy metal dusts, some chemotherapeutics, silica, malachite, dust, and exposure to radiation. 2−4 Immune response, 5 circulating immune cells, 6 and accumulated fibroblasts 7 are also involved in the development of pulmonary fibrosis. On the other hand, pulmonary fibrosis and assess disease severity can evaluated by interleukin levels. 8, 9 Also, oxidative stress can induce lung inflammation and aggravate the elevation of pulmonary fibrosis and eventually lead to bronchitis and emphysema. 10 To induce pulmonary fibrosis, rats are given triggering agents such as lipopolysaccharide. 11 Lipopolysaccharide is a component of the Gram-negative bacterial cell wall found in atmospheric pollutants. 12 When the bacteria infiltrate an organism's lung, the lipopolysaccharide stimulates macrophages, neutrophils, and epithelial cells to release inflammatory factors, causing lung tissues and airways to inflammate. 13 Polyphenols are a large group of phytochemicals that are naturally found in plants and beverages including fruit, vegetables, cocoa, cereal, tea, wine, beer, and coffee and are characterized by their hydroxylated phenyl groups. 12 One of the most common phenolic acids; gallic acid ( Figure 1 ), a flavoring agent and preservative in the food industry, 14, 15 has been reported for its biological and pharmacological activities, 16−21 cardioprotective, 22, 23 neuroprotective 24 gastroprotective, 25, 26 and metabolic disease prevention.

Nanoform of drugs has led to several applications in cancer diagnosis and treatment, 27 drug formulation, 28 biomarker mapping, 27 targeted therapy, molecular imaging, and development of nanomaterials. 29−32 Niosomes have become popular in drug delivery due to their unique properties. 33, 34 It is spherical in shape and consists of non-ionic surfactants at variable molar ratios with cholesterol. Niosomes can deliver insoluble and hydrophilic agents to the part to be treated in a minimum dose to decrease the side effects, enhance the therapeutic effects, increase the stability of the drug, prolong, and enhance drug absorption into the target area. 35−41 As a continuation of our interesting research in evaluation of therapeutic potential drugs of medical importance, 42−44 we report herein, a facile route to prepare a new nano-formula for gallic acid and evaluate its preventive efficacy against LPSinduced lung fibrosis in rats.

Encapsulating Efficiency. In the present study, niosomes reveal a high efficiency for encapsulating gallic acid (67 ± 3.0 %).

UV Spectrophotometry of Gallic Acid. In this work, we synthesized niosome nanocarriers encapsulating gallic acid (gallic acid-niosomes). The UV spectrum of free and nanocarriers is shown in Figure 2a . They have a strong absorption at 280 nm. Transmission electron microscopy (TEM) micrographs showed the spherical shape of the prepared nanocarriers (Figure 2b ). The size of gallic acidniosomes is 58−70 nm.

In-Vitro release. The release GA from the dialysis bag was rapid and reached equilibrium within 6 h ( Figure 3 ) due to its particles were unrestricted and had freedom of movement. The release of GA from niosomes took a longer time interval ( Figure 3 ) since GA was located within the niosomes.

FTIR. Figure 4 presents the mean Fourier-transform infrared spectroscopy (FTIR) spectra of free GA and GANE samples. Remarkably, the free GA sample demonstrates different spectra compared to the GANE. GA has a peak at 1701.87 cm −1 , which relates to a carbonyl group, and a band at 3295−3400 cm −1 corresponding to the phenolic O−H stretch group and the peak at 1030.77 cm −1 to the benzene ring. There are some differences in the GANE spectrum compared with that of free GA at the region between 3550 and 3200 cm −1 that corresponding to O−H group. This dissimilarity indicates that the incorporation of gallic acid into niosomes adds −OH groups to the aromatic rings in the spectrum of the GANE. The FTIR spectrum demonstrates that GA may be incorporated into niosomes.

GANE Cytotoxicity on A549 Lung Carcinoma Cell Line. The results reported in Table 1 and Figure 5 show that the incubation of GANE at different consternations (31.25, 62.50, 125, 250 , 500, and 1000 μg mL −1 ) with A549 lung carcinoma cell line resulted in viability % of 98. 23, 71.47, 28.13, 9.31, 5.39 GANE Cytotoxicity in Vivo. The results reported in Table  2 present the oral administration of GANEs in doses 800, 1200, 1600, 2000, 2400, and 2800 mg/kg b.w. Yielded mortalities 0, 2, 5, 8, 9, and 10 respectively. LD 50 dose of GENE s was 1640 mg/kg b.w.

Effect of GANE on Plasma TC, TG, and HDL-C Levels. Figure 6 shows plasma total cholesterol (TC), triglyceride (TG), and high-density lipoprotein (HDL)-C levels. Oral administration of LPS (200 μg/kg b.w.) led to a significant increase of TG level to 37.94%, and significant (P < 0.01) decrease in plasma TC and HDL-C level to 34.64 and 53.51%, respectively, compared to the control. Treatment of animals by the GANE (32.8 mg/kg.b.w.) significantly decreased the level of plasma TG level to 18.11%, and increased the plasma TC and HDL-C level significantly to 58.96 and 76.43%, respectively, compared to the group treated by LPS. Also, administration of LPS-treated rats with the GANE (82 mg/ kg.b.w.) significantly decreased the level of plasma TG level to 25.72%, and significantly increased the plasma TC and HDL-C level to 66.76 and 105.26% respectively, compared to the group treated by LPS. In addition, administration of LPStreated rats with dexamethasone (0.5 mg/kg) significantly increased the level of plasma TG level to 5.51%, and significantly decreased the plasma TC and HDL-C level to 135.15 and 23.17% respectively, compared to the group treated by LPS.

Effect of GANEs on Oxidative Stress on the Lungs. Table 3 shows lung superoxide dismutase (SOD), GPx, GSH, and MDA levels. Oral administration of LPS (200 μg/kg b.w.) led to decrease in lung SOD, GPx, and GSH significantly to 64.90, 66.11, and 56.93%, and significant decrease in the lung MDA to 171.17%, respectively, (P < 0.01) compared to the control group, which indicates acute lung fibrosis. Treatment of rats with the GANE (32.8 mg/kg.b.w.) significantly increased the level of the lung SOD, GPx, and GSH to 136.70, 87.10, and 83.28%, and led to a significant decrease in the lung MDA to 47.26%, respectively, compared to the group treated by LPS (P < 0.01). Also, administration of LPS-treated rats with the GANE (82 mg/kg.b.w.) significantly increased the level of lung SOD, GPx, and GSH to 160.45, 160.51, and 129.90%, and led to a significant decrease in the lung MDA to 99.99%, respectively, compared to the group treated by LPS (P < 0.01). While treatment of rats with dexamethasone (0.5 mg/ kg) increased the level of lung SOD, GPx, and GSH significantly to 49.49, 56.52, and 36.98%, and led to a significant decrease in lung MDA to 32.49%, respectively, compared to the group treated by LPS (P < 0.01).

Effect of GANEs on Inflammation Markers Levels in Lungs. Table 4 reveals a significant increase (P < 0.01) in TNF-α and IL-6 in rats treated with LPS (200 μg/kg b.w.) to 360.78 and 331.74%, and a decrease in lung IL-4 (P < 0.01) to 47.85%, respectively, compared to the control. The administration of GANEs (32.8 mg/kg.b.w.) clarified a decrease (P < 0.01) in lung TNF-α and IL-6 in rats treated with LPS to 59.74 and 54.15%, and a significant increase in lung IL-4 (P < 0.01) to 47.52%, respectively, compared to LPS-treated groups. Administration of GANEs (82 mg/kg.b.w.) presents a decrease (P < 0.01) in lung TNF-α and IL-6 in rats treated with LPS to 69.08 and 65.64%, and a significant increase (P < 0.01) in lung IL-4 to 75.11%, respectively, compared to LPS-treated groups (P < 0.01). Also, administration of dexamethasone (0.5 mg/ kg) found a significant decrease (P < 0.01) in lung TNF-α and IL-6 in rats treated with LPS to 72.76 and 73.50%, and significant increase in lung IL-4 (P < 0.01) to 83.11%, respectively, compared to LPS-treated groups (P < 0.01). Figures 7−9 declare a significant (P < 0.05) increased in lung p38MAPK, TGF-β, and NF-κB genes expression to 354.74, 514.56, and 276.47%, respectively, in LPS-treated groups compared with the normal rats, expressing a severe lung damage. When rats were administered with GANEs at 32.8 mg/kg, they exhibited a significant decrease in lung p38MAPK, TGF-β, and NF-κB genes expression to 28.00, 59.24, and 56.77%, respectively, compared to rats treated with LPS. The administration of rats with GANEs at 82 mg/kg.b.w. declared a significant decrease in lung p38MAPK, TGF-β, and NF-κB genes expression to 59.49, 69.51, and 67.44%, respectively, compared to rats treated with LPS. Also, treatment of rats with dexamethasone (0.5 mg/kg) decreased the level of lung p38MAPK, TGF-β, and NF-κB genes expression significantly (P < 0.05) to 51.38, 56.87, and 47.65%, respectively, compared to rats treated with LPS.

Histopathological Examination. Histopathological examination of control lung tissue groups (I) showed within normal arrangement and appearance of the lung tissue with no fibrosis or inflammation × 200 H&E (Figure 10a) . Moreover, the lung tissue of LPS-treated group (II), showed histological investigation with focal lesion consisted of thickening of alveolar walls with mild edema and few leukocytic cells infiltration (m and * respectively) X200H&E (Figure 10b) . Also, the lung tissue showed alveolar lumen and alveolar wall recovery (#) in LPS-treated rats with administrated GANEs (32.8 mg/kg.b.w.) compared to the LPS-treated (Figure 10c ) group (III). Furthermore, the histological examination of hepatocytes of groups (IV and V) showed a normal arrangement and apparency of the lung tissue with no fibrosis or inflammation (*) in LPS-treated rats administrated with GANEs (82 mg/kg.b.w.) and dexamethasone (0.5 mg/kg) compared to the LPS-treated group (Figure 10d ,e) groups (IV and V).

In the current study, a new GANE formula was designed for anticancer and lung protective estimation on the LPS-induced lung damage in rats.

Nanotechnology has changed the treatment ways of cancer and is fundamentally changing the pattern of treatment. It has had a major impact in selectively identifying cancer cells, delivering drugs, and overcoming the limitations of chemotherapies.

Niosomes, which have a structure of bilayer and consisted of nonionic surfactants and cholesterol self-association in an aqueous phase, are one of the most promising drug carriers. Niosomes are nonimmunogenic, biodegradable, and biocompatible. They have a long shelf-life, are extremely stable, and allow for controlled and/or sustained medicines to be delivered on the target site. 45 In the present study, we used niosomes as a GA carrier. Further studies reported the ability of niosomes to entrap a wide range of drugs. 46−48 Polyphenols can prevent cancer initiation and promotion through various mechanisms including inhibition of the activation of oncogenes and genes involved in oxidative stress and inflammation. 49, 50 Polyphenols can protect against carcinogenesis by modulating epigenetic aberrations such as histone modifications, DNA methylations, and microRNAs. 51 GA is one of the known effective polyphenols for treatment different types of cancers such as breast, melanoma, pancreatic, and colon cancer. 52, 53 In this work, our results referred to GANE has cytotoxicity to A549 lung carcinoma cell line with a low IC 50 value. This is consistent with former reports that revealed that GA has a cytotoxic effect on cancer cells. 54−59 LPS is a known compound that induces ALI/ARDS and induces ALI by primarily dysfunctional pulmonary surfactants, 60 As host receptor(s) recognizes LPS first, it initiates activation of a number of signal transduction cascades in lung cells.

In this study, the administration of LPS significantly increased the TC and TG levels and decreased significantly the plasma HDL-C level, which is an indicator of lipid peroxidation. Further, oral administration of GANEs at 32.8 and 82 mg/kg.b.w. and dexamethasone (0.5 mg/kg) provided significant protection against the LPS-induced lung damage. SOD, GPx, and GSH play an important biological function in antioxidant and cell protection processes by eliminating ROS to restrain cell damage. 61−63 The present results point to GANE-mediated induction of SOD, GPx, and GSH, which may helped in inhibition of the inflammatory response by reducing oxidative stress induced in LPS-treated rats. GANEs may protect cellular compounds from LPS oxidative damage via multiple mechanisms. 64 These include ROS scavenging, metal ion chelation, and antioxidant enzyme up-regulation and activation. 65, 66 In the current study, GANEs act as antioxidants on two levels: removing ROS and inhibiting ROS formation. GANEs remove ROS at the first level through direct scavenging or modulation of antioxidant enzyme activity; while at the second level, they prevent ROS formation and inhibition of ROS producing enzymes. 66 Whereas, LPS induced the generation of ROS 67 and can cause a significant increase in lung enzymes and lipid peroxidation, and a significant increase in MDA and a drop-in antioxidant enzyme activity in lungs. 68 In the present study, GANEs and dexamethasone induced transcription of IL-4, and suppresses TNF-α and IL-6 led to reduce ROS production and attenuate inflammation in vivo. For example, suppression of TGF-β led to inhibit the expression of p38MAPK and TGF-β gene expression. 69 On the other hand, inhibition of TNF-α and p38MAPK in GANEtreated rats led to decrease of IL-6 levels. 70 Also, TNF-α, IL-6, p38MAPK, TGF-β, and NF-κB reduced lung inflammation and ROS generation and inhibits adhesion molecule expression and monocyte adhesion in the lung tissue; 71−76 this effect appears to be mediated by antioxidant enzymes. 77 Our study hypothesized that IL-4 inhibits IL-6 and TNF-α and p38MAPK, TGF-β, and NF-κB gene expression, thereby preventing the degradation of lung tissue, protecting cell membrane integrity, and delaying the inflammation.

This study was confirmed by Wang et al. and Bataller et al., who reported that elevation of TNF-α and IL-6 levels in rats treated with LPS. 78, 79 The GANE could exert its antiinflammatory activity through certain mechanisms of (a) antioxidant and radical scavenging activities and (b) modulation of arachidonic acid metabolism (by regulating cyclooxygenase, phospholipase A2, and lipoxygenase) and nitric oxide synthase activity. 80 According to histopathological investigations, the GANE can protect lungs against LPSinduced lung fibrosis. This is evidenced by a reduced inflammatory response.

Overproduction of MDA and inflammatory mediators (TNF-α and IL-6) may cause DNA breakage. Although GANE treatment may enhance the repair of damaged DNA, it may also be a good protectors for lung tissues. High SOD, GPx activity in GANE-treated rats resulting in suppressed MDA production. Resynthesis of GSH also promotes DNA repair leading to lung protection. 81 In our study, we also demonstrate that GANE treatment reduced the increase in lung fibrosis in the lung from LPS-treated rats.

Furthermore, GANE proved efficacious to significantly lower total and biologically active lung TGF-β1 and NF-κB gene expression. TGF-β plays a central role in fibrotic disorders in different organs, including fibrosis of the lung. In fact, it stimulates collagen and fibronectin production in fibroblasts. 82 On the other hand, it can suppress the production of proteases that degrade the extracellular matrix. 83 TGF-β has been shown to be increased in LPS-induced lung fibrosis in the alveolar inflammatory infiltrate. 84 The present finding regarding the immediate induction of TNF-α is compatible with previous observations, 85 and the present findings clearly demonstrate that induction of TNF-α by intravenous administration of bleomycin was mediated by activation of p38 MAPK. Moreover, we observed significant suppression of p38 MAPK expression in the LPS-induced lung fibrosis model. Some previous studies demonstrated that another GANE reduced lipopolysaccharide-stimulated secretion of p38 MAPK expression in rats. 86−88 The protective effect of GANE against LPS-induced pulmonary fibrosis has not been reported according to our knowledge, and this may be the first study of its kind.

In the present study, GANE administration markedly suppressed apoptosis of the lung tissues. The role of p38 MAPK, TGF-β1, and NF-κB gene expression on apoptosis of various cell types is controversial, but it is possible that the suppression of apoptosis by inhibiting death signals. 89 

The study resulted in the observation that the GANE has a strong protective activity against LPS-induced pulmonary fibrosis through adjust the levels of biomarkers of oxidative stress and inflammation-mediated gene expression. Also, our investigation demonstrated that GANEs prevent the liberation of ROS for the damaged lung cell by inhibits lung IL-6 and TNF-α and p38MAPK, TGF-β, and NF-κB gene expression. This property leads us to imagine the existence of relation between GANE and cytokines and oxidative stress biomarkers, leading to a modulation of inflammatory process associated with lung fibrosis. It is clear that we will require further and detailed studies. Equipment and Material. Sonicator (Daihan, Korea) was used to form small vesicles niosomes and a cooling centrifuge (VS-18000M, Korea) was used to precipitate them. The UV absorbance of gallic acid was determined employing a spectrophotometer (JENWAY 6405, U.K.) at 280 nm. The UV spectra of free and niosomes encapsulated gallic acid were recorded by a UV spectrophotometer (Shimadzu, Japan).

In vitro drug release process was performed by Spectra/Por, MW cutoff12,000, Spectrum, Canada and a magnetic stirrer model (TK22, Kartell, Italy). The samples absorbance was determined at 280 nm by a spectrophotometer (UNICO UV-2000, China). The image of niosomes were investigated by TEM (JEOL JEM.1230, Japan). Moreover, the FTIR was conducted utilizing FT/IR-4100 (A Basic Vector, Germany).

Estimation of Cytokines. Lung cytokines: TNF-α, interleukin-6 (IL-6), and interleukin-4 (IL-4) were detected using a UV microplate reader (Thermo Electric Corp., Shanghai, China) by measuring the absorption at 450 nm.

Preparation of GANEs. Niosomes were formulated by a hydration method. Cholesterol and tween 80 (1:2) were dissolved in a round flask containing 50 mL of ethanol. Ethanol was evaporated by a rotary evaporator (63°C, 50 rpm) to produce dry thin films. The formed thin film was hydrated by PBS (pH 7.4) containing 3 gm of gallic acid. The produced niosomes were displayed to sonication to form small vesicle niosomes. At the end, a cooling centrifuge was used to precipitate niosomes at (12,000 rpm for 20 min). 41 Characterization of GANEs. Entrapment Efficiency. The supernatant having free GA was separated from the pellet (encapsulated one) by centrifugation (12,000 rpm, 30 min), the supernatant was isolated. The UV absorbance of gallic acid was determined at diverse concentrations at 280 nm. The calibration curve of gallic acid was obtained by drawing the absorbance against the concentration. The free gallic acid absorbance within the supernatant was specified spectrophotometrically at 280 nm. 39, 40, 90 The entrapment efficiency of niosomes was calculated from by

UV spectrophotometry of GANE. The UV spectra of free and niosomes encapsulated gallic acid were recorded by a UV spectrophotometer (Shimadzu, Japan). 91 In Vitro Drug Release. The dialysis manner was used to find in vitro release for free and encapsulated GA in PBS (pH 7.4). 40 Two milliliters of niosomes-encapsulated GA were introduced in a dialysis bag of cellulose acetate and sunken in PBS (100 mL) with stirring magnetically at 60 rpm. One milliliter was possessed at fixed time periods (every 1 h) of the immersed solution, replacing it with an equal volume of freshly prepared PBS. The samples absorbance was determined at 280 nm. The experiment was ended when the concentration of GA in the surrounding medium is constant.

TEM. Niosome-encapsulated GA was stained negatively by a 1% of phosphotungstic acid and left to air-dry and the sample was incubated on the grid for 10 min approximately, and then analyzed. 92 FTIR. FTIR spectra were obtained on lyophilized free and encapsulated gallic acid. Samples were ground with KBr at a ratio of 1:100 , and then are compressed by a hydraulic press with a pressure of 15,000 lbs. The pellets of the samples were scanned over the spectrum range 400−4000 cm −1 .

Determination of GANE Cytotoxicity on A549 Lung Carcinoma Cell Line. The GANE effect on the viability of A549cell lines was found by an assay of MTT. A 24-well plate contains 1.0 × 10 6 A549 cells/well, were exposed to GANE at concentrations of 31.5, 63.5, 125, 250, 500, and 1000 μg/mL for 24 h. A549 cells line without GANEs were used as control. Also, A549 cells line were cultured with MTT (20 μL/well of 5 mg/mL stock) about 4 h. The yellowish water-soluble MTT converts into formazan crystals water-insoluble which can be dissolved in 200 μL DMSO. A microplate reader was used to detect absorbance at 570 nm.

Animals. 90 Albino rats of weigh 150 ± 7 g (60 for LD 50 estimation and 30 for GANE anticancer efficiency) were brought from the animal house of National Cancer Institute, Cairo University, Giza, Egypt. The rats were provided water and a standard diet ad-libitum, observed daily, and kept in cages of polypropylene (20 cm × 34 cm x 47 cm) under a constant environmental condition throughout the experimental work. All experiments of animals were conducted according to the guidelines of Ethics Committee of the Faculty of Applied Health Sciences Technology, October 6 University, Egypt (registration no. 20210115).

LD 50 Determination for GANE. The LD 50 was determined in animal groups (each n = 10) administering GANE at doses of 800, 1200, 1600, 2000, 2400, and 2800 mg/kg orally. Saganuwan's method 23 was used to determine the LD 50 by the following formula D m : is the maximum dose that kills all animals. Z: is the average of dead animals between two consecutive groups. d: is a factor between two consecutive doses. n: is the animals number in each group. Animal Treatments. A 200 μg LPS was injected slowly intratracheal at day 1 and day 15 to induce Lung fibrosis in rats. 30 GANE was suspended in 1% Tween 80 and then administrated to rats by intragastric intubation. Table 5 showed the different groups of normal and treated rats.

On 16th day of the experiment, the blood samples were assembled in heparinized tubes, then centrifuged for 20 min at 1000×g. Blood samples were used to evaluate plasma levels of cholesterol, TGs, and cholesterol-high density lipoproteins. Commercial kits (Asan and Youngdong Pharmaceutical Co., Korea) were used for the analysis.

Lung Specimens. The lung tissue was homogenized in 3 mL of PBS (pH 7.5) and centrifuged (3000 g, 10 min). The supernatant was used to assess SOD, GSH, and TBARs calorimetrically using a kit of the Cayman Chemical Company (An Arbor, MI). The activity of GPx was measured indirectly by determination of NADPH oxidation at 340 nm.

Quantitative PCR Real-Time. The total RNA amount was extracted from lung of the rats, and parts of (10−15 μg) from the isolated RNA were exposed to PCR analysis in real time, by Sepasol-RNA1Super according to instructions of the manufacturer. Steps of RT-PCR gene expression have been measured. The expression level of a transforming growth factor-β (TGF-β1), P38 protein mitogen-activated kinase (p38MAPK), and nuclear factor-kappaB (NF-κB) was quantified. Tests were carried out in a 50 mL single-plex reaction mixture. The reaction was performed under conditions of pre-incubation at 50°C for 2 min, followed by 10 min with 40 cycles of 95°C in 15 s and 60°C in 1 min, respectively. The sequences of the primers were illustrated in the following Table 6 .

Histological Assessment. The lung tissues were subdivided into pieces for treatment by formalin (10% buffered formaldehyde solution). Samples were introduced in paraffin, sectioned, and stained with hematoxylin and eosin. The changes were observed by a light microscope.

Statistical Analysis. The obtained results were expressed as mean ± SD for six separate determinations for spectrophotometric and ELISA measurements as well as three separate determinations for the invitro cytotoxicity and PCR analysis of genes expression. All the data were analyzed by SPSS/20 Software using one-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test. P < 0.01 were considered to indicate statistical significance. The authors declare no competing financial interest. F: 5′-AGGGCGATGTGACGTTT-3′ R: 5′-CTGGCAGGGTGAAGTTGG-3′ TGF-β1 F:5′-ATTCAAGTCAACTGTGGAG-3′ R: 5′-: CGAAAGCCCTGTATTCCGTCT-3′ NF-κB F : 5 ′--GCGAGAGGAGCACAGATACC-3′ R: 5′-GCACAGCATTCAGGTCGTAG-3′ GAPDH (internal control for qRT-PCR) F: 5′-CTCAACTACATGGTCTACATGTTCCA-3′ R: 5′-CCATTCTCGGCCTTGA-CTGT-3′ β-actin (internal control for qRT-PCR) F-5′-GATTACTGCTCTGGCTCCTGC-3′ R-5′-GACTCATCGTACTCCTGCTTGC-3

Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis

Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis

Management of idiopathic pulmonary fibrosis

Immune Mechanisms in Pulmonary Fibrosis

Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms

Prophylactic Effect of Resveratrol Against Ethinylestradiol-Induced Liver Cholestasis

Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective

Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis

Synthesis of Cinnamyl and Caffeoyl Derivatives of Cucurbitacin-Eglycoside Isolated from Citrullus colocynthis Fruits and their Structures Antioxidant and Anti-inflammatory Activities Relationship

Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity

Biological activities, isolated compounds and HPLC profile of Verbascum nubicum

Assessment of the Efficiency of a Nanospherical Gallic Acid Dendrimer for Long-Term Preservation of Essential Oils: An Integrated Chemometric-Assisted FTIR Study

Chemical variation and antioxidant capacity of sumac

Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non-small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway

Improved anticancer effect of magnetite nanocomposite formulation of gallic acid (Fe3O4-PEG-GA) against lung

Delphinidin Chloride and Its Hydrolytic Metabolite Gallic Acid Promote Differentiation of Regulatory T cells and Have an Antiinflammatory Effect on the Allograft Model

Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complementary Altern

Comparison of antioxidant evaluation assays for investigating antioxidative activity of gallic acid and its alkyl esters in different food matrices

The antioxidant and antimicrobial activities of different phenolic acids grafted onto chitosan

El-Mehasseb, I. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can

Assessment of neuroprotective effects of gallic acid against glutamate-induced neurotoxicity in primary rat cortex neuronal culture

Design, synthesis, physicochemical, and pharmacological evaluation of gallic acid esters as non-ulcerogenic and gastroprotective antiinflammatory agents

Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug Des

Magnetically active Fe3O4 nanorods loaded with tissue plasminogen activator for enhanced thrombolysis

A sunscreen Nanoparticles Polymer Based on Prolonged Period of Protection

Astaxanthin; a promising protector against gentamicin-induced nephrotoxicity in rats

Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke

Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke

Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy

Application of Nanotechnology in Cancer Diagnosis and Therapy -A Mini-Review

Targeted drug delivery: a Review

Niosome: a future of targeted drug delivery systems

Niosomes as carrier in dermal drug delivery. Recent Adv. Novel Drug Carrier Syst

Effect of liposomes and niosomes on skin permeation of enoxacin

2012, 1, 981−993. (39) Abd-Elghany, A. A.; Mohamad, E. A. Ex-vivo transdermal delivery of Annona squamosa entrapped in niosomes by electroporation

Niosomes and liposomes as promising carriers for dermal delivery of annona squamosa extract. Braz

Evaluation of Natural Bioactive-Derived Punicalagin Niosomes in Skin-Aging Processes Accelerated by Oxidant and Ultraviolet Radiation

Antitumor impact of iron oxide nanoparticles in Ehrlich carcinomabearing mice

Phenolic Profiling and Therapeutic Potential of Certain Isolated Compounds from Parkia roxburghii against AChE Activity as well as GABAA α5, GSK-3β, and p38α MAP-Kinase Genes

Synthesis, characterization, equilibria and biological activity of dimethyltin(IV) complex with 1,4-piperazine

Synthesis and biological activities of some novel triazoloquinazolines and triazinoquinazolines containing benzenesulfonamide moieties

Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy

Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models

Tyloxapol niosomes as prospective drug delivery module for antiretroviral drug nevirapine

Mechanisms of aging and potential role of selected polyphenols in extending healthspan

Antioxidant and cytoprotective properties of plant extract from dry flowers as functional dyes for cosmetic products

Gallic acid: molecular rival of cancer

Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis

Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells

Luteolin activates ERK1/2-and Ca2+-dependent HO-1 induction that reduces LPS-induced HMGB1, iNOS/NO, and COX-2 expression in RAW264.7 cells and mitigates acute lung injury of endotoxin mice

Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism

Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation

Heme oxygenase-1 as a target for drug discovery

The molecular basis for the inhibition of phosphodiesterase-4D by three natural resveratrol analogs. Isolation, molecular docking, molecular dynamics simulations, binding free energy, and bioassay

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review

Antioxidant, anti-collagenase and anti-elastase activities of Phyllanthus emblica, Manilkara zapota and silymarin: an in vitro comparative study for anti-aging applications

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Anti-Inflammatory and Anti-Oxidant Activity of Portulaca oleracea Extract on LPS-Induced Rat Lung Injury

The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-β-Induced Epithelial-Mesenchymal Transition

p38 MAPK and NF-κB Collaborate to Induce Interleukin-6 Gene Expression and Release

Two new iridoid glucosides from the whole plant of patrinia scabiosifolia link

Dingchuan tang essential oil inhibits the production of inflammatory mediators via suppressing the IRAK/NF-κB

Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis

Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231

Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway

Liver fibrosis

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

Anti-inflammatory activity of fisetin in human gingival fibroblasts treated with lipopolysaccharide

Punicalagin reduces H2O2-induced cytotoxicity and apoptosis in PC12 cells by modulating the levels of reactive oxygen species

A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis

Peptidemediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis

Mitogen-activated protein kinase-activated protein kinase 2 inhibition attenuates fibroblast invasion and severe lung Fibrosis

Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway

induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts

The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury

Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors

Infected Patients with Chronic Diseases

Plasma Phospholipids: A promising simple biochemical parameter to evaluate COVID-19 infection severity

Pathophysiological roles of stress-activated protein kinases in pulmonary fibrosis

Rhodiola rosea L. Attenuates Cigarette Smoke and Lipopolysaccharide-Induced COPD in Rats via Inflammation Inhibition and Antioxidant and Antifibrosis Pathways. Evidence-Based Complementary Altern

Niosomes: Novel sustained release nonionic stable vesicular systems -An overview

Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo antiallograft rejection

Electroporation-enhanced entrapment of diclofenac sodium and ascorbic acid into DPPC liposomes

Control the activity of Erwinia amylovora bacterium by magnetic field

Wide-angle X-ray scattering as a probe for insulin denaturation